Management of Infected Bone Defects of the Lower Extremities by Three-Stage Induced Membrane Technique.
Adult
Aged
Bone Transplantation
/ methods
Debridement
/ methods
Female
Follow-Up Studies
Guided Tissue Regeneration
/ methods
Humans
Lower Extremity
/ surgery
Male
Middle Aged
Osteomyelitis
/ microbiology
Retrospective Studies
Surgical Flaps
/ transplantation
Transplantation, Autologous
/ methods
Transplantation, Homologous
/ methods
Treatment Outcome
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
12 Feb 2020
12 Feb 2020
Historique:
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
15
12
2020
Statut:
epublish
Résumé
BACKGROUND Infected bone defects are therapeutic challenges. Although the induced membrane technique has been used for this problem, there is a 3% to 20.7% failure to eradicate infection, and there have been few reports about its use in tuberculous infection. We present our three-stage induced membrane technique (TSIMT) for treating infected bone defects of the lower extremity. MATERIAL AND METHODS Forty-one adult patients with infected bone defects of the lower extremities treated by TSIMT were included in a retrospective case-series study between January 2013 and June 2018. The clinical, imaging and laboratory assessment outcomes were analyzed. RESULTS In the first stage, 3 patients had ankle tuberculous bone defects and 17 patients underwent 2-4 debridements. In the second stage, the average bone defect was 6.0 cm; 1 patient needed an anterolateral thigh flap to cover the wound. In the third stage, 10 patients underwent autograft mixed allograft, and 18 cases used internal fixation. The mean follow-up period was 23.3 months. All patients achieved bone union and clinical eradication of infection. Changes in Lower Extremity Functional Scale (LEFS) scores after 1 year of TSIMT and bone union time are associated with advanced age, longer duration of infected bone defects, active smoking, and external fixation (p<0.05), but are not dependent on bone defect size, debridement times, type of bone graft, or spacer-placing time (p>0.05). CONCLUSIONS TSIMT is effective in treating infected bone defects of the lower extremities. Advanced age, longer duration of infected bone defects, active smoking, and external fixation adversely affect bone union and recovery of infected extremities in a limited time span.
Identifiants
pubmed: 32047141
pii: 919925
doi: 10.12659/MSM.919925
pmc: PMC7034405
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e919925Références
Cochrane Database Syst Rev. 2013 Sep 06;(9):CD004439
pubmed: 24014191
Lancet. 2015 Mar 7;385(9971):875-82
pubmed: 25468170
Injury. 2011 Dec;42 Suppl 5:S18-23
pubmed: 22196905
Injury. 2015 Aug;46(8):1447-56
pubmed: 26007616
Int J Surg. 2017 Jun;42:110-116
pubmed: 28478316
Clin Orthop Relat Res. 1996 Dec;(333):245-51
pubmed: 8981903
Orthop Traumatol Surg Res. 2012 Feb;98(1):97-102
pubmed: 22244249
Clin Infect Dis. 2012 Feb 1;54(3):393-407
pubmed: 22157324
Acta Orthop. 2005 Jun;76(3):336-40
pubmed: 16156460
J Orthop Trauma. 2015 Nov;29(11):e454-8
pubmed: 26492454
J Orthop Trauma. 2015 Dec;29(12):554-7
pubmed: 25875174
BMC Surg. 2016 Aug 05;16(1):53
pubmed: 27491400
EFORT Open Rev. 2017 May 11;2(5):110-116
pubmed: 28630748
Strategies Trauma Limb Reconstr. 2009 Apr;4(1):13-8
pubmed: 19288056
Semin Plast Surg. 2009 May;23(2):141-7
pubmed: 20567736
Orthop Traumatol Surg Res. 2013 Jun;99(4):479-83
pubmed: 23608487
Injury. 2017 Feb;48(2):511-518
pubmed: 28088375
Clin Orthop Relat Res. 2003 Sep;(414):7-24
pubmed: 12966271
J Orthop Sports Phys Ther. 2016 Mar;46(3):200-16
pubmed: 26813750
Arch Orthop Trauma Surg. 2013 Sep;133(9):1183-96
pubmed: 23771127
EFORT Open Rev. 2017 Mar 13;1(5):128-135
pubmed: 28461939
Orthop Clin North Am. 2010 Jan;41(1):27-37; table of contents
pubmed: 19931050
Injury. 2019 Aug;50 Suppl 3:40-54
pubmed: 31378541
Plast Reconstr Surg. 2011 Jan;127 Suppl 1:177S-187S
pubmed: 21200289
Clin Orthop Relat Res. 2004 Oct;(427):47-51
pubmed: 15552135
Clin Orthop Relat Res. 1994 Jan;(298):229-39
pubmed: 8118980
J Bone Joint Surg Am. 2014 Apr 16;96(8):674-81
pubmed: 24740664
Orthop Traumatol Surg Res. 2018 Oct;104(6):911-915
pubmed: 29886150
Clin Orthop Relat Res. 2005 Aug;(437):91-6
pubmed: 16056032
J Am Acad Orthop Surg. 2005 Oct;13(6):417-27
pubmed: 16224114
J Bone Joint Surg Br. 2001 Apr;83(3):403-7
pubmed: 11341428
Clin Orthop Relat Res. 2004 Oct;(427):86-93
pubmed: 15552142
Antimicrob Agents Chemother. 2006 Jan;50(1):55-61
pubmed: 16377667
Injury. 2009 Nov;40(11):1231-6
pubmed: 19783249
Int Orthop. 2014 Sep;38(9):1971-8
pubmed: 24984595